Fund · CIK 2106181 · concentrated
Kalehua Capital Management LLC
Jun 30, 2026Filed Aug 19, 2026 · SEC filing ↗
Reported value$313M +21%
Positions26
Opened · sold out8 · 7
Holdings
Share positions at Jun 30, 2026| Stock | % of fund | Value | Shares | Since Q1 2026 |
|---|---|---|---|---|
| MANEVeradermics IncCOMMON STOCK | 11.4% | $35.8M | 291,390 | Added +17% |
| XFORX4 Pharmaceuticals IncCOMMON STOCK | 11.1% | $34.8M | 7,445,680 | Held |
| BOXXAlpha Architect 1-3 Mnth BoxALPHA ARCH 1-3 | 8.4% | $26.5M | 226,188 | Cut −33% |
| CMPSCompass Pathways PLCSPONSORED ADS | 7.4% | $23.2M | 1,639,384 | Held |
| SRZNSurrozen IncCOMMON STOCK | 6.4% | $20.0M | 770,356 | Held |
| ACRSAclaris Therapeutics IncStock | 6.2% | $19.4M | 3,664,730 | Added +16% |
| SIONSionna Therapeutics IncCOMMON STOCK | 5.5% | $17.3M | 394,144 | Held |
| IKTInhibikase Therapeutics IncCOMMON STOCK | 4.9% | $15.5M | 7,643,780 | Added +18% |
| PHVSPharvaris NVCOMMON STOCK | 4.4% | $13.7M | 397,544 | Held |
| KPTIKaryopharm Therapeutics IncCOMMON STOCK | 4.3% | $13.4M | 1,371,288 | New |
| SEPNSepterna IncStock | 4.2% | $13.0M | 389,088 | Held |
| IFRXInflarx NVCOM | 4.1% | $13.0M | 5,795,538 | New |
| Cyclerion Therapeutics IncCOM | 3.6% | $11.2M | 3,302,700 | New |
| QUREUniqure NVCOMMON STOCK | 2.3% | $7.3M | 158,814 | Cut −68% |
| LONALeonabio IncCOM | 2.3% | $7.2M | 787,402 | Held |
| Damora Therapeutics IncCOMMON STOCK | 2.3% | $7.2M | 278,000 | Held |
| MLTXMoonlake ImmunotherapeuticsStock | 2.2% | $6.8M | 351,468 | Held |
| KRROKorro Bio IncCOMMON STOCK | 1.7% | $5.3M | 405,040 | Added +270% |
| TYRATyra Biosciences IncCOMMON STOCK | 1.5% | $4.8M | 148,930 | Held |
| NVCTNuvectis Pharma IncCOMMON STOCK | 1.2% | $3.7M | 200,000 | New |
| Gossamer Bio IncStock | 1.2% | $3.7M | 22,298,726 | Added +26% |
| MISTMilestone Pharmaceuticals inCOM | 1.1% | $3.4M | 2,538,474 | New |
| ANLAdlai Nortye Group LtdSPONSORED ADS | 0.8% | $2.6M | 226,415 | New |
| ATYRAtyr Pharma IncCOM NEW | 0.7% | $2.1M | 3,576,334 | New |
| TILInstil Bio IncCOM NEW | 0.5% | $1.5M | 199,200 | Cut −38% |
| TCRXTscan Therapeutics IncCOM | 0.3% | $892K | 909,752 | New |
Sold out
Held at Mar 31, 2026, gone at Jun 30, 2026| Stock | % of fund in Q1 2026 | Value in Q1 2026 |
|---|---|---|
| RLAYRelay Therapeutics IncStock | 6.9% | $17.9M |
| ORKAOruka Therapeutics IncStock | 4.5% | $11.6M |
| PEPGPepgen IncStock | 1.2% | $3.1M |
| TNYATenaya Therapeutics IncCMN | 1.1% | $2.8M |
| KLRSKalaris Therapeutics IncCOM | 0.6% | $1.6M |
| DMACDiamedica Therapeutics IncCOMMON STOCK | 0.3% | $846K |
| LOOPLoop Industries IncCOM | 0.1% | $361K |